Medpace Holdings, Inc.
MEDP
Rangering i aksjer
#1303
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Aksjekurs
$622.03
Sist synkronisert: 2026-10-20
Markedsverdi
$17.36B
Endring (1 dag)
0.38%
Endring (1 år)
14.00%
Land
US
Handel Medpace Holdings, Inc. (MEDP)
Kategori
Healthcare
Antall utestående aksjer for Medpace Holdings, Inc. (MEDP)
Antall utestående aksjer per June 2026: 28.31M
Ifølge Medpace Holdings, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 28.31M. Ved slutten av December 2024 hadde selskapet 30.96M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Medpace Holdings, Inc. (MEDP) fra 2013 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 28.31M | -1.87% |
| 2025 | 28.85M | -6.82% |
| 2024 | 30.96M | 0.76% |
| 2023 | 30.72M | -5.14% |
| 2022 | 32.39M | -9.69% |
| 2021 | 35.86M | 0.64% |
| 2020 | 35.64M | -0.69% |
| 2019 | 35.88M | 0.94% |
| 2018 | 35.55M | -8.98% |
| 2017 | 39.06M | 9.43% |
| 2016 | 35.69M | -9.94% |
| 2015 | 39.63M | 34.65% |
| 2014 | 29.43M | -23.24% |
| 2013 | 38.35M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 371.00M | 1,210.58% |
US
|
|
| 705.30M | 2,391.52% |
US
|
|
| 143.28M | 406.14% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 896.18% |
US
|
